Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study

Affiliation auteurs!!!! Error affiliation !!!!
TitreIncidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: New insights from the ASSIST-ICD study
Type de publicationJournal Article
Year of Publication2019
AuteursMartins RP, Leclercq C, Bourenane H, Auffret V, Boule S, Loobuyck V, Dambrin C, Mondoly P, Sacher F, Bordachar P, Kindo M, Cardi T, Gaudard P, Rouviere P, Michel M, Gourraud J-B, Defaye P, Chavanon O, Kerneis C, Ghodhbane W, Pelce E, Gariboldi V, Pozzi M, Grinberg D, Litzler P-Y, Anselme F, Babatasi G, Belin A, Garnier F, Bielefeld M, Hamon D, Lellouche N, Pierre B, Bourguignon T, Eschallier R, D'Ostrevy N, Bories M-C, Jouan J, Vanhuyse F, Sadoul N, Flecher E, Galand V
JournalHEART RHYTHM
Volume16
Pagination1506-1512
Date PublishedOCT
Type of ArticleArticle
ISSN1547-5271
Mots-clésElectrical storm, Left ventricular assist device, Mortality, Ventricular arrhythmia, ventricular fibrillation, ventricular tachycardia
Résumé

{BACKGROUND Ventricular arrhythmias (VAs) can occur after continuous flow left ventricular assist device (LVAD) implantation as a single arrhythmic event or as electrical storm (ES) with multiple repetitive VA episodes. OBJECTIVE We aimed at analyzing the incidence, predictors, and clinical impact of ES in LVAD recipients. METHODS Patients analyzed were those included in the multi-center ASSIST-ICD observational study. ES was consensually defined as occurrence of >= 3 separate episodes of sustained VAs within a 24-hour interval. RESULTS Of 652 patients with an LVAD, 61 (9%) presented ES dur-ing a median follow-up period of 9.1 (interquartile range [IQR] 2.5-22.1) months. The first ES occurred after 17 (IQR 4.0-56.2) days post LVAD implantation, most of them during the first month after the device implantation (63%). The incidence then tended to decrease during the initial years of follow-up and increased again after the third year post LVAD implantation. History of VAs before LVAD implantation and heart failure duration > 84 months were independent predictors of ES. The occurrence of ES was associated with an increased early mortality since 20 patients (33%) died within the first 2 weeks of ES. Twenty-two patients (36.1%) presented at least 1 recurrence of ES, occurring 43.0 (IQR 8.0-69.0) days after the initial ES. Patients experiencing ES had a significantly lower 1-year survival rate than did those free from ES (log-rank

DOI10.1016/j.hrthm.2019.06.021